We did not adjust the models for HbA1c and glucose levels because their levels may be affected by reverse causation (see the causal pathway diagram, eFigure 2 in Supplement 2), so their inclusion in the model would bias the estimation of the associations between GLP-1RA or basal insulin and pancreatic cancer incidence. The gene discussed is INS; the disease is familial pancreatic carcinoma.